Which hedge funds own TGTX? TG THERAPEUTICS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
11 of the hedge funds tracked by WhaleCreep disclosed a position in TGTX (TG THERAPEUTICS INC) in their Q2 2026 13F filings, worth $353.0m in total. The largest holder by portfolio weight is Woodline Partners at 0.1% of its book. 2 managers opened a new position this quarter: Point72 Asset Management LP, Tudor Investment.
11tracked managers holding
2opened this quarter
0exited this quarter
Which hedge funds hold TGTX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Woodline Partners | Q2 2026 | 0.1% | $39.3m | 715,500 | 0% | held |
| D. E. Shaw & Co | Q2 2026 | 0.1% | $186.8m | 3,400,808 | 476% | added |
| Bridgewater Associates | Q2 2026 | 0.1% | $23.6m | 429,904 | 38% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.1% | $37.3m | 679,300 | 99% | added |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $14.6m | 264,963 | – | new |
| Tudor Investment | Q2 2026 | 0.0% | $5.2m | 93,920 | – | new |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $1.4m | 25,281 | 77% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $29.5m | 537,170 | -72% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $15.0m | 272,511 | 122% | added |
| Ancora Advisors | Q2 2026 | 0.0% | $16.5k | 300 | -0% | held |
| Marshall Wace | Q2 2026 | 0.0% | $316.3k | 5,758 | -78% | reduced |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Caxton Associates | Q4 2024 | 0.0% |
How has hedge fund ownership of TGTX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 11 | $353.0m |
| Q1 2026 | 9 | $134.3m |
| Q4 2025 | 4 | $23.8m |
| Q3 2025 | 4 | $28.3m |
| Q2 2025 | 3 | $47.8m |
| Q1 2025 | 3 | $31.0m |
| Q4 2024 | 1 | $498.4k |
| Q3 2024 | 2 | $60.4m |
| Q2 2024 | 4 | $42.7m |
| Q1 2024 | 4 | $40.8m |
| Q4 2023 | 3 | $45.3m |
| Q3 2023 | 5 | $19.5m |
| Q2 2023 | 5 | $77.7m |
| Q1 2023 | 2 | $68.3m |
| Q4 2022 | 4 | $143.2m |
| Q3 2022 | 6 | $58.2m |
Counts every tracked manager that disclosed TGTX in that quarter's filing, including managers that have since stopped filing.